Gerstmann-straussler-scheinker Disease
Gerstmann-Sträussler-Scheinker disease (GSS) is a rare and fatal neurological disorder that is inherited in an autosomal dominant manner. This disease is included in the group of prion diseases, which are characterized by the presence of abnormal proteins, called prions, that accumulate in the brain and cause neuronal death, leading to progressive neurological symptoms. GSS is caused by a mutation in the PRNP gene, which codes for the prion protein. The mutation results in the abnormal folding of the prion protein, leading to its accumulation in the brain and the formation of amyloid plaques. Individuals with GSS usually begin to develop symptoms in their 40s or 50s. These may include changes in behavior and personality, memory loss, impaired coordination, and difficulty with speech and swallowing. As the disease progresses, individuals may also experience muscle stiffness and weakness, vision disturbances, and seizures. Currently, there is no cure for GSS. Treatment is generally supportive and aims to alleviate the symptoms of the disease. However, there are ongoing research efforts to identify potential therapies that could slow or halt the progression of the disease. In conclusion, GSS is a rare and devastating neurological disorder that is caused by the accumulation of abnormal prion proteins in the brain. While there is no cure for GSS, research in this area continues with the aim of identifying effective treatments for this disorder.
← Journal of Neurological Research And Therapy